[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625018":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":16,"locations":22,"responsibleParty":43,"collaborators":10,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":47,"sex":53,"minAge":10,"maxAge":10,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Fundacion Miguel Servet","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients diagnosed with long COVID",null,[12],{"name":13,"affiliation":14,"role":15},"Patricia Fanlo Mateo, MD, PhD","Hospital Universitario de Navarra. Pamplona. Spain","PRINCIPAL_INVESTIGATOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Ruth García Rey, SC","CONTACT","+3484822163","ruth.garcia.rey@navarra.es",[23],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":37},"Hospital Universitario de Navarra","RECRUITING","Pamplona","Navarre","31008","Spain","ES",{"type":32,"coordinates":33},"Point",[34,35],-1.64323,42.81687,{"lat":35,"lon":34},[38,42],{"name":39,"role":19,"phone":40,"phoneExt":10,"email":41},"Patricia Fanlo Mateo., MD, PhD","+34639668497","patricia.fanlo.mateo@navarra.es",{"name":13,"role":15,"phone":10,"phoneExt":10,"email":10},{"type":44,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100625018","persistent-covid-19-registry-in-navarre-100625018",false,"NCT07417176","Persistent COVID-19 Registry in Navarre.","Persistent COVID-19 Registry in Navarre. (Persicov-19)","PERSICOV-19","Inclusion Criteria:\n\n* History of confirmed SARS-CoV-2 infection\n* Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection\n* The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist.\n\nExclusion Criteria:\n\n* The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.","ALL",{"count":55,"type":56},200,"ESTIMATED","3 Months","OBSERVATIONAL","The goal of this observational study is to deepen our understanding of long COVID by determining the prevalence of the main complications and medium- to long-term sequelae of COVID-19 in Navarre.\n\nSociodemographic variables such as age, sex, ethnicity, smoking history, and comorbidities will be collected, as well as clinical and disease management variables such as persistent COVID-19 symptoms at 3 months, all with the aim of characterizing patients with long COVID.\n\nAll patient data will be collected in a single visit.",[61,62],"Long COVID Symptoms","Long COVI",[64,65,66],"long covid 19","Long COVID syndrome","Long COVID Fatigue","2026-02-18",{"date":69,"type":70},"2026-02-20","ACTUAL",{"date":72,"type":70},"2021-01-04",{"date":74,"type":56},"2026-03-31",{"name":5,"class":6},1]